Cambridge Investment Research Advisors
ULBI icon

Cambridge Investment Research Advisors’s Ultralife ULBI Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ULBI Stock Details ULBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,600
Closed -$63K – 2785
2020
Q3 		$63K Hold
10,600
– – ﹤0.01% 2432
2020
Q2 		$74K Hold
10,600
– – ﹤0.01% 2347
2020
Q1 		$55K Buy
+10,600
New +$72.5K ﹤0.01% 2178

Other funds holding ULBI

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors's ULBI Position: Q4 2020 in Review

Cambridge Investment Research Advisors sold out of Ultralife (ULBI) in Q4 2020, closing a stake of 10,600 shares — an estimated $63K sold.

Cambridge Investment Research Advisors first reported a position in ULBI in Q1 2020 and held it in 3 quarters. The position peaked at $74K in Q2 2020. 48 funds tracked by Wall St. Rank hold ULBI as of Q4 2020.

  • Cambridge Investment Research Advisors reported no remaining Ultralife position as of Q4 2020 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 10,600 Ultralife shares in Q4 2020, an estimated $63K.
  • Cambridge Investment Research Advisors first reported a position in Ultralife in Q1 2020 and held it in 3 quarters.
  • Cambridge Investment Research Advisors's Ultralife position peaked at $74K in Q2 2020.
  • 48 funds tracked by Wall St. Rank held Ultralife as of Q4 2020.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2020, filed 4 Feb 2021.